SwePub - search: WFRF:(Darpo B)

Enumeration	Reference	Cover	Find
1.	Timmers, M, et al. (author) Evaluating Potential QT Effects of JNJ-54861911, a BACE Inhibitor in Single- and Multiple-Ascending Dose Studies, and a Thorough QT Trial With Additional Retrospective Confirmation, Using Concentration-QTc Analysis 2018 In: Journal of clinical pharmacology. - : Wiley. - 1552-4604 .- 0091-2700. ; 58:7, s. 952-964 Journal article (peer-reviewed)
2.	Darpo, B, et al. (author) Evaluation of the QT effect of a combination of piperaquine and a novel anti-malarial drug candidate OZ439, for the treatment of uncomplicated malaria 2015 In: British journal of clinical pharmacology. - : Wiley. - 1365-2125 .- 0306-5251. ; 80:4, s. 706-715 Journal article (peer-reviewed)
3.	Darpo, B, et al. (author) Exenatide at therapeutic and supratherapeutic concentrations does not prolong the QTc interval in healthy subjects 2013 In: British journal of clinical pharmacology. - : Wiley. - 1365-2125 .- 0306-5251. ; 75:4, s. 979-989 Journal article (peer-reviewed)
4.	Darpo, B, et al. (author) Results from the IQ-CSRC prospective study support replacement of the thorough QT study by QT assessment in the early clinical phase 2015 In: Clinical pharmacology and therapeutics. - : Wiley. - 1532-6535 .- 0009-9236. ; 97:4, s. 326-335 Journal article (peer-reviewed)
5.	DARPO, B, et al. (author) Tolerance and effects of almokalant, a new selective Ik blocking agent, on ventricular repolarization and on sino-atrial and atrioventricular nodal function in the heart: a study in healthy, male volunteers utilizing transesophageal atrial stimulation 1995 In: Journal of cardiovascular pharmacology. - : Ovid Technologies (Wolters Kluwer Health). - 0160-2446. ; 25:5, s. 681-690 Journal article (peer-reviewed)
6.	Houltz, B, et al. (author) Effects of the Ikr-blocker almokalant and predictors of conversion of chronic atrial tachyarrhythmias to sinus rhythm. A prospective study 1999 In: Cardiovascular drugs and therapy. - : Springer Science and Business Media LLC. - 0920-3206. ; 13:4, s. 329-338 Journal article (peer-reviewed)
7.	Houltz, B, et al. (author) Electrocardiographic and Clinical Predictors of Torsades de Pointes Induced by Almokalant Infusion in patients With Chronic Atrial Fibrillatio and Flutter 1998 In: PACE. ; 21, s. 1044- Journal article (peer-reviewed)
8.	Houltz, B, et al. (author) Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective study 1998 In: Pacing and clinical electrophysiology : PACE. - : Wiley. - 0147-8389 .- 1540-8159. ; 21:5, s. 1044-1057 Journal article (peer-reviewed)
9.	Murphy, PJ, et al. (author) Concentration-Response Modeling of ECG Data From Early-Phase Clinical Studies as an Alternative Clinical and Regulatory Approach to Assessing QT Risk - Experience From the Development Program of Lemborexant 2017 In: Journal of clinical pharmacology. - : Wiley. - 1552-4604 .- 0091-2700. ; 57:1, s. 96-104 Journal article (peer-reviewed)
10.	Azie, NE, et al. (author) Comparing methods of measurement for detecting drug-induced changes in the QT interval: implications for thoroughly conducted ECG studies 2004 In: Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc. - 1082-720X. ; 9:2, s. 166-174 Journal article (peer-reviewed)
11.	Bass, AS, et al. (author) International Life Sciences Institute (Health and Environmental Sciences Institute, HESI) initiative on moving towards better predictors of drug-induced torsades de pointes 2008 In: British journal of pharmacology. - : Wiley. - 0007-1188. ; 154:7, s. 1491-1501 Journal article (other academic/artistic)
12.	Bass, AS, et al. (author) Moving towards better predictors of drug-induced torsades de pointes 2008 In: British journal of pharmacology. - : Wiley. - 0007-1188. ; 154:7, s. 1550-1553 Journal article (peer-reviewed)
13.	Boyd, JL, et al. (author) Lack of clinically meaningful changes in cardiac effects from co-administration of ozanimod and a beta-blocker or a calcium channel blocker 2017 In: MULTIPLE SCLEROSIS JOURNAL. - 1352-4585. ; 23, s. 913-914 Conference paper (other academic/artistic)
14.	Couderc, JP, et al. (author) Identification of sotalol-induced changes in repolarization with T wave area-based repolarization duration parameters 2003 In: Journal of electrocardiology. - : Elsevier BV. - 0022-0736. ; 3636 Suppl, s. 115-120 Journal article (peer-reviewed)
15.	Darpo, B, et al. (author) A Study in Patients with Wolff-Parkinson-White Syndrome and Atrioventricular Nodal Reentrant Tachycardia. 1995 In: Journal of Cardiovascular Pharmacology. ; 26, s. 198- Journal article (peer-reviewed)
16.	Darpo, B, et al. (author) Albiglutide Does Not Prolong QTc Interval in Healthy Subjects: A Thorough ECG Study 2014 In: Diabetes therapy : research, treatment and education of diabetes and related disorders. - : Springer Science and Business Media LLC. - 1869-6953. ; 5:1, s. 141-153 Journal article (peer-reviewed)
17.	Darpo, B, et al. (author) Almokalant - A selective class III antiarrhythmic compound 1996 In: CARDIOVASCULAR DRUG REVIEWS. - : Wiley. - 0897-5957 .- 1527-3466. ; 14:1, s. 60-83 Research review (other academic/artistic)
18.	Darpo, B, et al. (author) Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTc modelling in a phase 1 study with oral rac-sotalol 2014 In: British journal of clinical pharmacology. - : Wiley. - 1365-2125 .- 0306-5251. ; 77:3, s. 522-531 Journal article (peer-reviewed)
19.	Darpo, B, et al. (author) Assessment of frequency dependency of the class III effects of almokalant: a study using programmed stimulation and recording of monophasic action potentials and ventricular paced QT intervals 1996 In: Cardiovascular drugs and therapy. - 0920-3206. ; 10:5, s. 539-547 Journal article (peer-reviewed)
20.	Darpo, B, et al. (author) Assessment of the cardiac safety and pharmacokinetics of a short course, twice daily dose of orally-administered mifepristone in healthy male subjects 2013 In: Cardiology journal. - 1898-018X. ; 20:2, s. 152-160 Journal article (peer-reviewed)
21.	Darpo, B, et al. (author) Cardiac Safety Research Consortium: can the thorough QT/QTc study be replaced by early QT assessment in routine clinical pharmacology studies? Scientific update and a research proposal for a path forward 2014 In: American heart journal. - : Elsevier BV. - 1097-6744 .- 0002-8703. ; 168:3, s. 262-272 Journal article (peer-reviewed)
22.	Darpo, B, et al. (author) Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 guideline 2006 In: Journal of clinical pharmacology. - : Wiley. - 0091-2700. ; 46:5, s. 498-507 Journal article (peer-reviewed)
23.	Darpo, B, et al. (author) Design of the "Thorough QT Study" 2008 In: Clinical pharmacology and therapeutics. - : Springer Science and Business Media LLC. - 1532-6535 .- 0009-9236. ; 83:4, s. 528-529 Journal article (other academic/artistic)
24.	Darpo, B (author) Detection and reporting of drug-induced proarrhythmias: room for improvement 2007 In: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. - : Oxford University Press (OUP). - 1099-5129. ; 99 Suppl 4, s. 23-36 Journal article (peer-reviewed)
25.	Darpo, B, et al. (author) Detection of ECG effects of (2R,4R)-monatin, a sweet flavored isomer of a component first identified in the root bark of the Sclerochitin ilicifolius plant 2016 In: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. - : Elsevier BV. - 1873-6351. ; 91, s. 217-224 Journal article (peer-reviewed)

Skapa referenser, mejla, bekava och länka

Permalink

Träfflista för sökning "WFRF:(Darpo B) "

Refine your search

Year